The invention generally relates to devices and related methods for treating intracardiac defects. More particularly, the invention provides an intracardiac occluder for the percutaneous closure of intracardiac defects.
The human heart is divided into four compartments or chambers. The left and right atria are located in the upper portion of the heart and the left and right ventricles are located in the lower portion of the heart. The left and right atria are separated from each other by a muscular wall, the interatrial septum, while the ventricles are separated by the interventricular septum.
Either congenitally or by acquisition, abnormal openings, holes, or shunts can occur between the chambers of the heart or between the great vessels, causing blood to flow along an anomalous pathway therethrough. Such deformities are usually congenital and originate during fetal life when the heart forms from a folded tube into a four chambered, two unit system. The deformities result from the incomplete formation of the septum, or muscular wall, between the chambers of the heart and can cause significant problems. Ultimately, the deformities add strain on the heart, which may result in heart failure if they are not corrected.
One such deformity or defect, a patent foramen ovale (PFO), is a persistent, one-way, usually flap-like opening in the wall between the right atrium and left atrium of the heart. Since left atrial pressure is normally higher than right atrial pressure, the flap typically stays closed. Under certain conditions, however, right atrial pressure exceeds left atrial pressure, creating the possibility for right to left shunting that can allow blood clots to enter the systemic circulation. This is particularly worrisome to patients who are prone to forming venous thrombi, such as those with deep vein thrombosis or clotting abnormalities.
Nonsurgical (i.e., percutaneous) closure of a PFO, as well as similar intracardiac defects such as an atrial septal defect, a ventricular septal defect, and closure of the left atrial appendage, is possible using a variety of mechanical closure devices. These percutaneously, transvascularly introduced devices, which avoid the potential side effects often associated with standard anticoagulation therapy of a patient having one of these defects, typically consist of a metallic structural framework that is combined with a synthetic or biological tissue scaffold material applied to the structural framework.
The structural framework of the prior art intracardiac occluders are often stiff and rigid, lacking the flexibility necessary to conform with irregularly shaped intracardiac defects. This results in trauma to surrounding tissues, chronic inflammation, residual leaks, and even breakage of the occluder, impairing closure of the defect to which the intracardiac occluder is applied.
The present invention provides a device for occluding intracardiac defects. The device includes a proximal occlusion shell comprising a flexible and resilient support structure and a scaffold material. The proximal occlusion shell is connected to a distal occlusion shell by a central body portion. The support structure comprises a variety of modifications that enhance the flexibility of the device.
In one aspect of the invention, the intracardiac occluder comprises a central body portion, a proximal occlusion shell and a distal occlusion shell. The proximal occlusion shell comprises a plurality of arms, at least one of the arms comprising a curve extending from a hub end of the arm to a free end of the arm in a constantly changing plane around a central axis. The central body portion is secured between the proximal occlusion shell and the distal occlusion shell for positioning the device in a defect. In another embodiment, the proximal occlusion shell comprises a second arm comprising a curve extending from a hub end to a free end in a constantly changing plane around a central axis. The second arm may curve in a direction opposite the direction of the at least one arm comprising a curve, or it may curve in the same direction. The second arm comprising a curve and the at least one arm comprising a curve may also be adjacent to one another. In a further embodiment, the proximal occlusion shell further comprises at least one arm wherein the arm curves such that the free end of the at least one arm is in the same plane as the hub end of the arm and all other points on that arm.
In a further embodiment, an arm of a proximal occlusion shell is made of a material selected from the group consisting of nitinol, MP35N, polymers, bioresorbable polymers, and a metal. In yet another embodiment at least one arm of the proximal occlusion shell comprises a plurality of wires, while in a further embodiment, the cross-section of at least one of the wires is selected from the group consisting of a circle, a triangle, a square, a rectangle, and an oval. In another embodiment, the arms are joint-free.
In another aspect of the invention, an intracardiac occluder comprises a central body portion, a proximal occlusion shell and a distal occlusion shell. The proximal occlusion shell comprises a plurality of arms, each arm extending from a hub end to a free end, wherein at least one of the plurality of arms comprises a curve extending from the hub end to the free end and at least another of the plurality of arms is straight. The central body portion is secured between said proximal occlusion shell and said distal occlusion shell for positioning the device in a defect. In one embodiment, at least one arm of a proximal occlusion shell comprises a curve extending from a hub end to a free end in a constantly changing plane around a central axis, while in a further embodiment, the free end of the at least one arm comprising a curve is in the same plane as the hub end and all other points on the at least one arm comprising a curve. In yet another embodiment, the at least one arm of the proximal occlusion shell comprising a curve extending from the hub end to the free end is adjacent to the at least one arm that is straight. In yet another embodiment, the proximal occlusion shell comprises at least one arm that is straight which differs in length compared to another arm that is straight, while in yet another embodiment, the proximal occlusion shell comprises at least one arm comprising a curve which differs in length compared to another arm that comprises a curve. In a further embodiment, the plurality of arms of the proximal occlusion shell are joint-free.
In another aspect of the invention, an intracardiac occluder comprises a central body portion, a proximal occlusion shell, and a distal occlusion shell. The proximal occlusion shell comprises a first arm comprising a curve extending from the hub end to the free end and a second arm comprising a curve extending from the hub end to the free end, the second arm curving in a direction opposite to the curving direction of the first arm, and the central body portion is secured between the proximal occlusion shell and the distal occlusion shell for positioning the device in a defect. In another embodiment, the second arm of the proximal occlusion shell comprising a curve is adjacent to the first arm comprising a curve. In a further embodiment, at least one of the first arm or the second arm of the proximal occlusion shell comprises a curve extending from the hub end to the free end in a constantly changing plane around a central axis, while in another embodiment, at least one of the first arm or the second arm of the proximal occlusion shell curves such that the hub end is in the same plane as the free end and all other points on the arm. In yet another embodiment, the hub end and the free end of the first arm of the proximal occlusion shell is in a first plane and the hub end and the free end of the second arm are in a second plane. In yet another embodiment, the proximal occlusion shell further comprises at least one straight arm, while in another embodiment, the plurality of arms are joint-free.
The foregoing and other objects, aspects, features and advantages of the invention will become more apparent from the following description and from the claims.
In the drawings, like reference characters generally refer to the same parts throughout the different views. Also, the drawings are not necessarily to scale, emphasis instead generally being placed upon illustrating the principles of the invention.
The present invention is directed to intracardiac occluders, such as intracardiac occluders, for the repair of intracardiac defects in a patient, such as, for example, a patent foramen ovale (PFO), an atrial septal defect, and a ventricular septal defect, and for occlusion of a left atrial appendage. All of the following embodiments of the invention include one or more features to improve the conformability and fatigue resistance of an intracardiac occluder at an intracardiac anatomical site such as an intracardiac defect, for example, a PFO.
In one embodiment, the proximal occlusion shell 52 includes a proximal support frame 56, and the distal occlusion shell 54 includes a distal support frame 58. In one embodiment, the proximal support frame 56 and the distal support frame 58 are part of an overall support structure 60 that also includes a central body portion 27. The central body portion 27, for example, joins the proximal occlusion shell 52 to the distal occlusion shell 54. For example, in one embodiment, the proximal support frame 56 of the proximal occlusion shell 52 is joined by the central body portion 27 to the distal support frame 58 of the distal occlusion shell 54. In another embodiment, the central body portion 27 joins the center of the proximal occlusion shell 52 to, for example, the center of the distal occlusion shell 54.
With continued reference to
Referring still to
With continued reference to
Furthermore, with continued reference to
In a further embodiment, each arm of the support frame 56, 58 curves such that the hub end 23 and the free end 21 of each arm 20 remain in the same plane as all points on that arm 20. In a particular embodiment, each arm 20 of the support frame 56, 58 curves such that the hub end 23 and the free end 21 of each arm 20 remain in the same plane as the hub end 23 and free end 21 of each other arm 20. In a further embodiment, each arm 20 of the support frame 56, 58 curves such that the hub end 23 and the free end 21 of each arm 20 remain in the same plane as the hub end 23, free end 21 and each other point on each other arm 20, resulting in a two-dimensional or planar profile of the support frame 56, 58 as exemplified in
In another embodiment, while each arm 20 of the support frame 56, 58 of the occlusion shell 52, 54 curves such that the hub end 23 and the free end 21 of each arm 20 remain in the same plane as all points on that arm 20, at least a second arm 20, including its hub end 23, free end 21, and all points on the second arm 20 are in a different plane than the hub end 23, free end 21, and all other points on at least one other arm 20 (not shown). The result is a three-dimensional or non-planar support frame 56, 58.
For example, in one embodiment, the plane of one arm 20, including the hub end 23, free end 21 and all points on the arm 20, intersects the plane of at least a second arm 20, where the plane of the second arm 20 includes the hub end 23, free end 21, and all points on the second arm 20. In another embodiment, the plane of one arm 20 including the hub end 23, free end 21, and all points on that arm 20 intersects at an angle of 90 degrees the plane of at least a second arm 20, where the plane of the second arm 20 includes the hub end 23, free end 21, and all points on the second arm 20. In another embodiment, the angle of intersection is less than 90 degrees. In a further embodiment, the plane of at least one arm 20 including the hub end 23, free end 21 and all points on the arm 20, does not intersect the plane of at least a second arm 20 including the hub end 23, free end 21 and all points on the second arm 20.
With continued reference to
As used herein, a helically curved arm 20, in one embodiment, comprises a spiral. In a further embodiment, a helically curved arm 20 includes a continuous curve or portion thereof traced by a point moving around fixed point in the same plane while steadily increasing or diminishing its distance from the fixed point, like a watch-spring. In one embodiment, the helically curved arm 20 including the curve traced by a point moving around the fixed point in the same plane includes less than one full turn, whereas in another embodiment, the curve includes more than one full turn, i.e., a turn of greater than 360°. In a further embodiment, the helically curved arm 20 includes a curve including at least one full turn and at least one less than full turn. In yet another embodiment, the curve of the helically curved arm 20 extends from the hub end 23 of the arm 20 to the free end 21 of the arm 20.
In another embodiment, a helically curved arm 20 is a corkscrew or a coil. In a further embodiment, the helically curved arm 20 comprises a curve or portion of a curve traced by a point moving around and simultaneously advancing along a cylinder or cone. In one embodiment, the curve advances along a cylinder such the diameter of each turn in the curve is constant. In another embodiment, the curve advances around a cone such that the diameter of each consecutive turn of the curve increases, whereas in another embodiment, the curve advances around a cone such that the diameter of each consecutive turn of the curve decreases.
In yet another embodiment, a helically curved arm 20 comprises a curve or a portion of a curve extending from a hub end 23 to a free end 21 in a constantly changing plane around a central axis. In another embodiment, a helically curved arm 20 includes a curve formed by a straight line traced on a plane when the plane is wrapped around a cylinder, i.e., a curve that when unrolled into a plane becomes a straight line. In one embodiment, the distance between a first turn and a second turn of the helically curved arm 20 and the second turn and a third turn of the helically curved arm 20 is constant, while in another embodiment, the distance between the first turn and the second turn, and the second turn and the third turn is different.
With reference to
The support frame 56, 58 shown can be used either as the proximal occlusion shell support frame 56 or the distal occlusion shell support frame 58. As shown in
Once the catheter is appropriately positioned in the patient's heart, as shown in
As shown in
Once the deployment of the occluder 50 is complete, the catheter 120 and position wire 128 are then withdrawn from the patient leaving the opened intracardiac occluder 50 with the occlusion shells 52, 54 positioned on each side of the intracardiac defect 14, for example, a PFO. Because the occlusion shells 52, 54 are free to move relative to each other about the central body portion 27, the intracardiac occluder 50 can be used in applications in which it is desirable that the occluder elements are not directly opposed to one another. For example, such an intracardiac occluder 50 can be used to correct flap-like or tunnel-like defects in the atrial septum.
Variations, modifications, and other implementations of what is described herein will occur to those of ordinary skill in the art without departing from the spirit and the scope of the invention as claimed. Accordingly, the invention is to be defined not by the preceding illustrative description, but instead by the spirit and scope of the following claims.
This application claims priority to and benefit of U.S. Provisional application 60/664,988, filed on Mar. 24, 2005, the entirety of which is incorporated by reference herein.
Number | Name | Date | Kind |
---|---|---|---|
3874388 | King et al. | Apr 1975 | A |
4007743 | Blake | Feb 1977 | A |
4696300 | Anderson | Sep 1987 | A |
4710192 | Liotta et al. | Dec 1987 | A |
4836204 | Landymore et al. | Jun 1989 | A |
4917089 | Sideris | Apr 1990 | A |
5108420 | Marks | Apr 1992 | A |
5171259 | Inoue | Dec 1992 | A |
5284488 | Sideris | Feb 1994 | A |
5312341 | Turi | May 1994 | A |
5334217 | Das | Aug 1994 | A |
5425744 | Fagan et al. | Jun 1995 | A |
5433727 | Sideris | Jul 1995 | A |
5451235 | Lock et al. | Sep 1995 | A |
5507811 | Koike et al. | Apr 1996 | A |
5578045 | Das | Nov 1996 | A |
5597378 | Jervis | Jan 1997 | A |
5634936 | Linden et al. | Jun 1997 | A |
5702421 | Schneidt | Dec 1997 | A |
5709707 | Lock et al. | Jan 1998 | A |
5725552 | Kotula et al. | Mar 1998 | A |
5733294 | Forber et al. | Mar 1998 | A |
5741297 | Simon | Apr 1998 | A |
5797960 | Stevens et al. | Aug 1998 | A |
5823956 | Roth et al. | Oct 1998 | A |
5829447 | Stevens et al. | Nov 1998 | A |
5853422 | Huebsch et al. | Dec 1998 | A |
5855614 | Stevens et al. | Jan 1999 | A |
5861003 | Latson et al. | Jan 1999 | A |
5865791 | Whayne et al. | Feb 1999 | A |
5879366 | Shaw et al. | Mar 1999 | A |
5893856 | Jacob et al. | Apr 1999 | A |
5904703 | Gilson | May 1999 | A |
5919200 | Stambaugh et al. | Jul 1999 | A |
5924424 | Stevens et al. | Jul 1999 | A |
5944738 | Amplatz et al. | Aug 1999 | A |
5976174 | Ruiz | Nov 1999 | A |
5997556 | Tanner | Dec 1999 | A |
6010517 | Baccaro | Jan 2000 | A |
6024756 | Huebsch et al. | Feb 2000 | A |
6077291 | Das | Jun 2000 | A |
6079414 | Roth | Jun 2000 | A |
6080182 | Shaw et al. | Jun 2000 | A |
6106532 | Koike et al. | Aug 2000 | A |
6113609 | Adams | Sep 2000 | A |
6117159 | Huebsch et al. | Sep 2000 | A |
6132438 | Fleischman et al. | Oct 2000 | A |
6152144 | Lesh et al. | Nov 2000 | A |
6165183 | Kuehn et al. | Dec 2000 | A |
6171329 | Shaw et al. | Jan 2001 | B1 |
6174322 | Schneidt | Jan 2001 | B1 |
6206907 | Marino et al. | Mar 2001 | B1 |
6214029 | Thill et al. | Apr 2001 | B1 |
6221092 | Koike et al. | Apr 2001 | B1 |
6231561 | Frazier et al. | May 2001 | B1 |
6270515 | Linden et al. | Aug 2001 | B1 |
6290674 | Roue et al. | Sep 2001 | B1 |
6312446 | Huebsch et al. | Nov 2001 | B1 |
6328727 | Frazier et al. | Dec 2001 | B1 |
6348041 | Klint | Feb 2002 | B1 |
6352531 | O'Connor et al. | Mar 2002 | B1 |
6352552 | Levinson et al. | Mar 2002 | B1 |
6355052 | Neuss et al. | Mar 2002 | B1 |
6375671 | Kobayashi et al. | Apr 2002 | B1 |
6379368 | Corcoran et al. | Apr 2002 | B1 |
6383146 | Klint | May 2002 | B1 |
6387060 | Jalisi | May 2002 | B1 |
6387104 | Pugsley et al. | May 2002 | B1 |
6419669 | Frazier et al. | Jul 2002 | B1 |
6436088 | Frazier et al. | Aug 2002 | B2 |
6440152 | Gainor et al. | Aug 2002 | B1 |
6482210 | Skiba et al. | Nov 2002 | B1 |
6488706 | Solymar | Dec 2002 | B1 |
6544272 | Jakob et al. | Apr 2003 | B1 |
6551303 | Van Tassel et al. | Apr 2003 | B1 |
6551344 | Thill | Apr 2003 | B2 |
6596013 | Yang et al. | Jul 2003 | B2 |
6616685 | Rousseau | Sep 2003 | B2 |
6623508 | Shaw et al. | Sep 2003 | B2 |
6623518 | Thompson et al. | Sep 2003 | B2 |
6656206 | Corcoran et al. | Dec 2003 | B2 |
6666873 | Cassell | Dec 2003 | B1 |
6712836 | Berg et al. | Mar 2004 | B1 |
20010034537 | Shaw et al. | Oct 2001 | A1 |
20010037129 | Thill | Nov 2001 | A1 |
20010041914 | Frazier et al. | Nov 2001 | A1 |
20010041915 | Roue et al. | Nov 2001 | A1 |
20020010481 | Jayaraman | Jan 2002 | A1 |
20020029048 | Miller | Mar 2002 | A1 |
20020035374 | Borillo et al. | Mar 2002 | A1 |
20020077555 | Schwartz | Jun 2002 | A1 |
20020111636 | Fleischman et al. | Aug 2002 | A1 |
20020111647 | Khairkhahan et al. | Aug 2002 | A1 |
20020128680 | Pavlovic | Sep 2002 | A1 |
20020183786 | Girton | Dec 2002 | A1 |
20020183787 | Wahr et al. | Dec 2002 | A1 |
20030028213 | Thill et al. | Feb 2003 | A1 |
20030045893 | Ginn | Mar 2003 | A1 |
20030045901 | Opolski | Mar 2003 | A1 |
20030050665 | Ginn | Mar 2003 | A1 |
20030065379 | Babbs et al. | Apr 2003 | A1 |
20030073979 | Naimark et al. | Apr 2003 | A1 |
20030139819 | Beer et al. | Jul 2003 | A1 |
20030144694 | Chanduszko et al. | Jul 2003 | A1 |
20030171739 | Murphy et al. | Sep 2003 | A1 |
20030191495 | Ryan et al. | Oct 2003 | A1 |
20030191526 | Van Tassel et al. | Oct 2003 | A1 |
20030195530 | Thill | Oct 2003 | A1 |
20030195531 | Gardiner et al. | Oct 2003 | A1 |
20030204203 | Khairkhahan et al. | Oct 2003 | A1 |
20040044361 | Frazier et al. | Mar 2004 | A1 |
20040143277 | Marino et al. | Jul 2004 | A1 |
20040143291 | Corcoran et al. | Jul 2004 | A1 |
20040143293 | Marino et al. | Jul 2004 | A1 |
20040143294 | Corcoran et al. | Jul 2004 | A1 |
20040176799 | Chanduszko et al. | Sep 2004 | A1 |
20040210301 | Obermiller | Oct 2004 | A1 |
20040220596 | Frazier et al. | Nov 2004 | A1 |
20040267191 | Gifford, III et al. | Dec 2004 | A1 |
20040267306 | Blaeser et al. | Dec 2004 | A1 |
20050065547 | Marino et al. | Mar 2005 | A1 |
20050070957 | Das | Mar 2005 | A1 |
20050125032 | Whisenant et al. | Jun 2005 | A1 |
20050131460 | Gifford, III et al. | Jun 2005 | A1 |
20050192627 | Whisenant et al. | Sep 2005 | A1 |
20050273119 | Widomski et al. | Dec 2005 | A1 |
20060155327 | Briganti et al. | Jul 2006 | A1 |
20100234880 | Abbott et al. | Sep 2010 | A1 |
Number | Date | Country |
---|---|---|
1 013 227 | Jun 2000 | EP |
1 046 375 | Oct 2000 | EP |
0 724 406 | Dec 2001 | EP |
1 222 897 | Jul 2002 | EP |
2 407 985 | May 2005 | GB |
WO 9510983 | Apr 1995 | WO |
WO 9838920 | Sep 1998 | WO |
WO 9839053 | Sep 1998 | WO |
WO 9839063 | Sep 1998 | WO |
WO 9905977 | Feb 1999 | WO |
WO 9925254 | May 1999 | WO |
WO 9930640 | Jun 1999 | WO |
WO 0027292 | May 2000 | WO |
WO 0108600 | Feb 2001 | WO |
WO 0130266 | May 2001 | WO |
WO 0130267 | May 2001 | WO |
WO 0130268 | May 2001 | WO |
WO 0149185 | Jul 2001 | WO |
WO 0193783 | Dec 2001 | WO |
WO 0224106 | Mar 2002 | WO |
WO 03022159 | Mar 2003 | WO |
WO 03059152 | Jul 2003 | WO |
WO 03061481 | Jul 2003 | WO |
WO 03073944 | Sep 2003 | WO |
WO 03103476 | Dec 2003 | WO |
WO 2004028348 | Apr 2004 | WO |
Entry |
---|
Cook Incorporated product brochure for “Bird's Nest® Vena Cava Filter,” (2000). |
Hanson, (1981), “Metals that Remember,” Science, (81):44-47. |
Kramer, (2003), “PFO and Stroke: The Hidden Connection,” Endovascular Today, available at http://www.evtoday.com/03—archive/0903/101.html, accessed on Apr. 21, 2004. |
Latson, (1993), “Transcatheter Closure of Atrial Septal Defects,” Chapter 17 in Transcatheter Therapy in Pediatric Cardiology, pp. 335-348, Wiley and Sons, Inc. |
Simon et al., (1977), “A Vena Cava Filter Using Thermal Shape Memory Alloy,” Radiology, 125(1):89-94. |
Simon et al., (1980), “Transvenous Devices for the Management of Pulmonary Embolism,” Cardiovascular and Internventional Radiology, 3:308-318. |
Stöckel, (2000), “Nitinol Medical Devices and Implants,” Proceedings of the International Conference on Shape Memory and Superelastic Technologies, pp. 532-541. |
Szili-Torok et al., (2001), “Transseptal Left Heart Catherisation Guided by Intracardiac Echocardiography,” Heart, (86):e11. |
Number | Date | Country | |
---|---|---|---|
20060217761 A1 | Sep 2006 | US |
Number | Date | Country | |
---|---|---|---|
60664988 | Mar 2005 | US |